Diagnosis of Intracranial Hypertension Using TCCD, ONSD and ODH by Bedside Ultrasound
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY ·
Trial Information
Current as of October 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to measure pressure inside the brain without using invasive tools in people who have had a head injury. Normally, doctors measure this pressure by placing a device inside the head, which can be uncomfortable and carries some risks. This study will look at three non-invasive methods using bedside ultrasound—special scans that don’t require surgery—to see how well they can detect high brain pressure compared to the traditional invasive method. The goal is to find easier and safer ways to monitor patients after a head injury.
The trial is open to adults aged 65 to 74 who have experienced a head injury and need an invasive pressure monitor placed as part of their care. If you join, you will have several ultrasound tests done at the same time as the invasive monitor is in place, so doctors can compare the results. This study is not yet enrolling participants but aims to help improve how doctors check brain pressure in the future, potentially making it safer and more comfortable for patients.
Gender
ALL
Eligibility criteria
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported